Tuesday, June 2, 2020 | ePaper

FFs to get Tk 12,000 as monthly honorarium

  • Print
BSS, Dhaka :
The government is likely to propose increasing the monthly allowance for the freedom fighters (FF) to Taka 12,000 from Taka 10,000 in the next national budget, to be placed in parliament on Thursday.
"The Liberation War Affairs Ministry has proposed to enhance the amount of the allocation to Taka 3,385 crore in the upcoming budget, which was Taka 3,305 crore in the current fiscal year," an official of the ministry told BSS here .
He said the government led by Prime Minister Sheikh Hasina introduced
FF allowances as part of her determination to show honour and respect to them.
To this end, the government is likely to increase allowances for FFs keeping other festival allowances unchanged in the new fiscal year beginning on July 1, according to the ministry information.
The government currently provides a monthly allowance of Tk 10,000 to each of the country's 2,00,000 FFs for their contribution to the country's War of Liberation in 1971.
Besides, the freedom fighters are entitled to other financial benefits under the titles of Victory Day allowance, two Eid bonuses and Boishakhi (Bengali New Year) allowance and a 125-litre of water daily free of cost in the metropolitan areas under miscellaneous benefits.
In the next national budget, each FF will get Taka 12,000 as monthly honourarium, Taka 10,000 as each Eid bonus, Taka 2,000 as Baishakhi allowance.
Apart from this, the government is also providing medical allowances for the injured freedom fighters and ration for the martyred families and disabled freedom fighters.

More News For this Category

Commuters wait for public bus at the capital's Rayer Bazar on Monday, a day after the authorities reopened offices and transport services in a restricted manner.

Commuters wait for public bus at the capital's Rayer Bazar on Monday, a day after the authorities reopened offices and transport services in a restricted manner.

.

Heavy traffic congestion across the capital on Monday after the government lifted months long nationwide coronavirus shutdown. This photo was taken from Airport Road.

Heavy traffic congestion across the capital on Monday after the government lifted months long nationwide coronavirus shutdown. This photo was taken from Airport Road.

.

Experts advise not to use unproven drugs to treat Covid-19

Staff Reporter :As the search for a remedy to COVID-19 continues in full swing, the national technical advisory committee on the coronavirus has warned against using any unproven medicine

HC rejects bail petition of ex-DIG Prisons Bazlur

Staff Reporter :The High Court on Monday rejected a bail petition filed by suspended Deputy Inspector General (DIG) of Prisons Bazlur Rashid in connection with a corruption case filed

HC for judicial inquiry into fatal fire at United Hospital

Staff Reporter :A writ petition has been filed with the High Court seeking a judicial inquiry into last week's fire incident at United Hospital's COVID-19 unit which left five

Dr Kamal for nat’l effort in preventing coronavirus

Staff Reporter :Gono Forum President and Jatiya Oikya Front leader Dr Kamal Hossain has urged Prime Minister to take coordinated national efforts in preventing coronavirus, says media report.   In

Pressure grows to release jailed prince

Al Jazeera News :A $2m US lobbying effort and petitions from European legislators are piling pressure on Saudi Arabia to release a philanthropist prince jailed for two years

Writ challenges virtual court functions

Staff Reporter :A Supreme Court lawyer on Monday filed a writ petition with the High Court challenging the Chief Justice's decision to run virtual activities of the courts across

Three die in Panchagarh lightning

UNB, Panchagarh :Three people including a father-son duo were killed in two separate lightning strikes in two villages of Tetulia upazila on Monday.The deceased were identified as Mohammad Ali,

Remdesivir helped moderate Covid-19 patients improve: Gilead Sciences

Reuters :Gilead Sciences Inc said on Monday its antiviral drug remdesivir showed improvement in patients with moderate COVID-19 in a late-stage study.Remdesivir is being closely watched after the US